| HOME >> MEDICINE >> TECHNOLOGY |
Table 11.4 Late-Stage Non-Narcotic Pipeline Agents, 2010 (Continued)
Table 11.5 Late-Stage Anti-Arthritic Pipeline Agents, 2010
Table 11.6 Late-Stage Anti-Migraine Pipeline Agents, 2010
Table 11.7 Late-Stage Anti-Epileptic Pipeline Agents, 2010
Table 11.8 Late-Stage Local Anaesthetic Pipeline Agents, 2010
List of Figures
Figure 3.1 The Global Pain Drug Market: Sales Forecast ($m), 2010-2025
Figure 3.2 Leading Pain Market Segments: Sales Forecasts ($m), 2010-2025
Figure 3.3 Leading Pain Market Segments: Sales ($m) & Market Shares (%), 2009, 2015, 2010 & 2015
Figure 3.4 Leading Pain Markets: Market Shares (%), 2009
Figure 3.5 Leading Pain Markets' Market Shares (%), 2025
Figure 4.1 The Global Narcotics Market: Sales Forecast ($m), 2010-2025
Figure 4.2 Oxycontin Sales Forecast ($m), 2010-2025
Figure 4.3 Duragesic Sales Forecast ($m), 2010-2025
Figure 4.4 Fentanyl Myla Sales Forecast ($m), 2010-2025
Figure 4.5 Actiq Sales Forecast ($m), 2010-2025
Figure 4.6 Other Products: Sales Forecast ($m), 2010-2025
Figure 5.1 The Global Non-Narcotics Market: Sales Forecast ($m), 2010-2025
Figure 5.2 Efferalgan Sales Forecast ($m), 2010-2025
Figure 5.3 Tylenol Sales Forecast ($m), 2010-2025
Figure 5.4 Doliprane Sales Forecast ($m), 2010-2025
Figure
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |